House panels launch investigation into controversial Alzheimer's drug | The Hill: Healthcare Policy

Two House committees on Friday announced they are launching an investigation into the Food and Drug Administration’s (FDA) controversial approval of a new Alzheimer’s drug, including the drug’s $56,000 a year price.The announcement from House Energy...